MamaLift Plus is a prescription?only digital therapeutic intervention for the treatment of mild to moderate postpartum depression using several different neurobehavioral interventions.
A wide range of delivery options may be effective for addressing symptoms of depression in perinatal individuals, and could therefore be leveraged to expand access to treatments.
A routinely administered single-item measure of sleep disturbance could identify pregnant individuals who are at risk for PPD and may benefit from depression prevention efforts.
Psychological interventions may reduce the severity of perinatal anxiety symptoms.
This preliminary study suggests that web-based interventions with coaching are feasible, acceptable, and potentially effective treatment options for women with mild to moderate postpartum depression and/or anxiety.
In this randomized controlled trial, a CBT-based workshop for women with PPD led to clinically meaningful reductions in depression and anxiety.
This review suggests that CBT can be used to target depression during pregnancy and can be delivered using a digital platform.
Cognitive-behavioral therapy specifically designed for insomnia (CBT-I) is a useful adjunct or alternative to medication for women during pregnancy.
This study will evaluate the effectiveness of two digital (app- or web-based) interventions for the treatment of OCD.
Psychological interventions provided by nurses and midwives can significantly reduce the severity of perinatal depressive symptoms.
